𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The influence of steady-state ciprofloxacin on the pharmacokinetics and pharmacodynamics of a single dose of diazepam in healthy volunteers

✍ Scribed by F. Kamali; S. H. L. Thomas; C. Edwards

Publisher
Springer
Year
1993
Tongue
English
Weight
247 KB
Volume
44
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The single dose pharmacokinetics and saf
The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers
✍ Harri Kanerva; Olavi Kilkku; Esa Heinonen; Antti Helminen; Juha Rouru; Simo Tarp πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 2 views

The pharmacokinetics and tolerability of a new putative non-benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An open dose-escalation design was used to study doses from 0.2 to 50 mg in 18 healthy male volunteers. In the second study doses from 50 to 150 mg

A review of the pharmacokinetics, tolera
A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers
✍ P. Rosenzweig; M. Canal; A. Patat; L. Bergougnan; I. Zieleniuk; G. Bianchetti πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 131 KB

Amisulpride binds selectively to dopamine D(2) and D(3) receptors in the limbic system. Low doses of amisulpride preferentially block presynaptic D(2)/D(3)-dopamine autoreceptors, thereby enhancing dopaminergic transmission, whereas higher doses block postsynaptic receptors, thus inhibiting dopamine

Pharmacokinetics and pharmacodynamics of
Pharmacokinetics and pharmacodynamics of a slow-release formulation of diltiazem after the administration of a single and repeated doses to healthy volunteers
✍ M. Lefebvre; Y. Lacasse; J. SpΓ©nard; D. Geadah; R. Moisan; D. Gossard; H. Landri πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 782 KB

Diltiazem is a calcium antagonist used in angina pectoris and hypertension. There is little information concerning the slow-release (SR) formulation in the literature. The pharmacokinetics of diltiazem SR (120 mg) have been assessed over a 36 h period in healthy volunteers after single-(SD) and mult

Pharmacokinetics of the active metabolit
Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose
✍ D. Beermann; H. G. Schaefer; M. Wargenau; B. Heibel; Y. Sturm; J. Kuhlmann πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 557 KB

The pharmacokinetics of BAY w 8199, the active metabolite of the prodrug repirinast (BAY u 2372), has been investigated after oral administration of 150, 300 and 450 mg repirinast to twelve healthy male Caucasians. Plasma BAY w 8199 concentrations were very variable between subjects. The mean peak l